Although these differences did not quite reach statistical significance (p=0.08), when viewed in the context of the results with MHHshRNA tumors, these results confirm that WT1 expression modulates in vivo tumor growth of Ewing sarcoma xenografts. The gene discussed is WT1; the disease is neoplasm.